Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer Shares Plunge After U.S. Court Defeat in Roundup Case
05:26am, Monday, 24'th Mar 2025
Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court reached a verdict in favor of the plaintiff.
Bayer hit with $2 billion Roundup verdict in US state of Georgia cancer case
08:02am, Saturday, 22'nd Mar 2025
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said late o
Is Bayer (BAYRY) Stock Undervalued Right Now?
10:41am, Thursday, 20'th Mar 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Litigation, Debt, And Decline - Yet Bayer Seems Like A Buy
02:04am, Thursday, 20'th Mar 2025
Bayer's stock surged 24.5% since December 2024, yet remains a speculative investment due to significant risks like high debt and ongoing litigation. 2024 annual results showed a 2.2% sales decline, wi
Bayer's sNDA for Kerendia Label Expansion Gets FDA's Priority Review
01:55pm, Tuesday, 18'th Mar 2025
The FDA accepts and grants priority review to BAYRY's sNDA for Kerendia to treat patients with a common form of heart failure.
Bayer welcomes new law in U.S. state to better shield it against glyphosate litigation
06:27am, Monday, 17'th Mar 2025
Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to better protect the maker of crop protection chemicals against glyphosate litigation.
Bayer wins Brazil injunction in soy patent row with farmers
12:18pm, Friday, 14'th Mar 2025
Germany's Bayer has won an injunction to suspend a court ruling that gave Brazilian soybean farmers the right to reimbursement for royalties paid for expired patents of genetically modified soy seeds,
Exclusive: Bayer share drop draws market regulator's scrutiny, source says
11:25am, Tuesday, 11'th Mar 2025
Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential capital increase, a regulatory source told
Bayer told analysts of cash call plan a day before official statement
03:59pm, Friday, 07'th Mar 2025
Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed heavily on the stock, analysts' notes seen
Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
10:40am, Friday, 07'th Mar 2025
Here is how Bayer Aktiengesellschaft (BAYRY) and AbbVie (ABBV) have performed compared to their sector so far this year.
Bayer warns US lawmakers it may halt Roundup sales without stronger legal protections: report
09:47am, Friday, 07'th Mar 2025
Bayer AG (ETR:BAYN, OTC:BAYZF) has told US lawmakers it may halt sales of its popular Roundup weedkiller in the United States unless stronger legal protections are implemented to protect the company
Bayer seeks investor approval for 35% cash call to gird for litigation
06:43am, Friday, 07'th Mar 2025
Bayer said on Friday it would seek shareholder approval to raise fresh equity capital worth close to 35% of its currently outstanding shares over the next three years to be ready for any U.S. litigati
Bayer eyes exit from popular Roundup amid US legal risks
01:49am, Friday, 07'th Mar 2025
Bayer has warned U.S. lawmakers it could stop selling the popular Roundup weedkiller if they cannot provide better legal protection against product liability litigation, according to a financial analy
Bayer Q4 Earnings In Line, Revenues Top on Nubeqa, Kerendia Sales
04:00pm, Wednesday, 05'th Mar 2025
BAYRY's fourth-quarter earnings match expectations. Revenues top estimates, driven by the strong performance of its pharmaceutical business.
Bayer Aktiengesellschaft (BAYZF) Q4 2024 Earnings Call Transcript
01:32pm, Wednesday, 05'th Mar 2025
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Jost Reinhard - IR Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo San
